703 related articles for article (PubMed ID: 29642941)
41. RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells.
Li A; Xie J; Lv L; Zheng Z; Yang W; Zhuo W; Yang S; Cai D; Duan J; Liu P; Min J; Wei J
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38639179
[TBL] [Abstract][Full Text] [Related]
42. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application.
Ge Y; Mu W; Ba Q; Li J; Jiang Y; Xia Q; Wang H
Cancer Lett; 2020 May; 477():41-48. PubMed ID: 32112905
[TBL] [Abstract][Full Text] [Related]
43. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
44. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
[TBL] [Abstract][Full Text] [Related]
45. Recent progress in the emerging role of exosome in hepatocellular carcinoma.
Abudoureyimu M; Zhou H; Zhi Y; Wang T; Feng B; Wang R; Chu X
Cell Prolif; 2019 Mar; 52(2):e12541. PubMed ID: 30397975
[TBL] [Abstract][Full Text] [Related]
46. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
[TBL] [Abstract][Full Text] [Related]
47. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
[TBL] [Abstract][Full Text] [Related]
48. Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA.
Liang J; Zhang X; He S; Miao Y; Wu N; Li J; Gan Y
J Control Release; 2018 Sep; 286():348-357. PubMed ID: 30077738
[TBL] [Abstract][Full Text] [Related]
49. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
50. High expression of circulating exosomal circAKT3 is associated with higher recurrence in HCC patients undergoing surgical treatment.
Luo Y; Liu F; Gui R
Surg Oncol; 2020 Jun; 33():276-281. PubMed ID: 32561093
[TBL] [Abstract][Full Text] [Related]
51. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Fang T; Lv H; Lv G; Li T; Wang C; Han Q; Yu L; Su B; Guo L; Huang S; Cao D; Tang L; Tang S; Wu M; Yang W; Wang H
Nat Commun; 2018 Jan; 9(1):191. PubMed ID: 29335551
[TBL] [Abstract][Full Text] [Related]
52. The functional role of exosome in hepatocellular carcinoma.
Liu H; Li B
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2085-2095. PubMed ID: 30062486
[TBL] [Abstract][Full Text] [Related]
53. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells.
Rios-Colon L; Arthur E; Niture S; Qi Q; Moore JT; Kumar D
Cells; 2020 Aug; 9(9):. PubMed ID: 32872417
[TBL] [Abstract][Full Text] [Related]
54. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
55. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
Suda T
World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
[TBL] [Abstract][Full Text] [Related]
56. Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.
Huang C; Tang S; Shen D; Li X; Liang L; Ding Y; Xu B
Oncol Lett; 2021 Feb; 21(2):168. PubMed ID: 33552286
[TBL] [Abstract][Full Text] [Related]
57. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1
Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G
J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680
[TBL] [Abstract][Full Text] [Related]
58. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.
Wang H; Lu Z; Zhao X
J Hematol Oncol; 2019 Dec; 12(1):133. PubMed ID: 31815633
[TBL] [Abstract][Full Text] [Related]
59. Assessment of endogenous reference gene suitability for serum exosomal microRNA expression analysis in liver carcinoma resection studies.
Li Y; Xiang GM; Liu LL; Liu C; Liu F; Jiang DN; Pu XY
Mol Med Rep; 2015 Sep; 12(3):4683-4691. PubMed ID: 26082194
[TBL] [Abstract][Full Text] [Related]
60. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
